UK markets close in 4 hours 27 minutes

Oncopeptides AB (publ) (0RN4.IL)

IOB - IOB Delayed price. Currency in SEK
Add to watchlist
2.8350-0.6225 (-18.00%)
As of 04:24PM BST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-245,791
-249,111
-337,951
-1,430,317
-1,594,693
-
Depreciation & amortisation
4,540
11,040
17,161
14,994
14,403
-
Stock-based compensation
32,493
-
-
-
-
32,493
Change in working capital
-40,547
-55,967
-109,233
-38,082
142,270
-
Inventory
-
-1,334
0
-319
-429
-
Other working capital
-257,974
-279,609
-423,016
-1,516,730
-1,313,689
-
Other non-cash items
-
-
1,362
3,798
15
-
Net cash provided by operating activities
-257,858
-279,493
-420,509
-1,516,391
-1,296,509
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,628
-116
-2,507
-339
-17,180
-
Purchases of investments
-
-1
0
0
-3,131
-
Sales/maturities of investments
-
-
0
0
184
0
Other investing activities
-
1
-
-
-
-
Net cash used for investing activities
-116
-116
-2,507
-339
-20,127
-
Net change in cash
-151,287
-172,721
-30,614
-482,700
6,825
-
Cash at beginning of period
253,904
344,515
362,187
840,255
926,186
-
Cash at end of period
102,618
173,407
344,515
362,187
840,255
-
Free cash flow
Operating cash flow
-257,858
-279,493
-420,509
-1,516,391
-1,296,509
-
Capital expenditure
-2,628
-116
-2,507
-339
-17,180
-
Free cash flow
-257,974
-279,609
-423,016
-1,516,730
-1,313,689
-